Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Corporate Insiders Raiding The Piggy Bank To Buy Shares Of These Three Companies

Page 1 of 2

It has been quite a while since the last time the stock market declined by 10%. The recent correction has been triggered by three primary factors: worries about China’s economic slowdown; falling commodity markets, which put downward pressure on emerging markets and commodity exporters; and expectations of an interest rate hike in September. Nevertheless, the recent correction has created great buying opportunities that cannot be missed. To this end, investors should monitor the trading activity of corporate insiders to see which company’s executives feel the shares of their companies have been hit overly hard and are now undervalued, and are buying them up as a result. The Insider Monkey team identified three companies that had noteworthy insider purchases on Wednesday. In the following article, we will take a thorough look at the insider trading activity of these companies, which are Virginia National Bankshares Corporation (OTCMKTS:VABK), Harvard Bioscience Inc. (NASDAQ:HBIO), and Church & Dwight Co. Inc. (NYSE:CHD).

Trading; business; secret; Business Man Whispering; Insider Trading; executive; japan; the negotiation; director; company; working; meeting; boss; manager;


Most investors can’t outperform the stock market by individually picking stocks because stock returns aren’t evenly distributed. A randomly picked stock has only a 35% to 45% chance (depending on the investment horizon) to outperform the market. There are a few exceptions, one of which is when it comes to purchases made by corporate insiders. Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012. We have been forward testing the performance of these stock picks since the end of August 2012 and they have returned more than 118% over the ensuing 36 months, outperforming the S&P 500 Index by nearly 61 percentage points (read the details here). The trick is focusing only on the best small-cap stock picks of funds, not their large-cap stock picks which are extensively covered by analysts and followed by almost everybody.

We will start off by looking into the insider activity at Virginia National Bankshares Corporation (OTCMKTS:VABK), which operates as the holding company for Virginia National Bank. William Bolling Izard, who has been a Director of the company since 2012, reported purchasing 4,000 shares for $23 each on September 2, in addition to the 1,000 shares bought at the beginning of the week. Following these transactions, the director owns 26,531 shares. The recent mini-crash of the broader market has not affected the shares of this holding company too much, as they are traded over-the-counter. Even so, the recent insider buying activity at the company might suggest that the shares are currently trading at a discount nonetheless. Virginia National Bank’s management has outlined a clear goal of growing its loan balances without hurting the asset quality of its loan portfolio. The company’s total loans amounted to $367.1 million on June 30, which was up by $53.8 million from the figure registered on December 31, 2014. Therefore, this increase indicates that the company is making progress towards achieving this objective.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!